Free Trial

Keybank National Association OH Cuts Stock Holdings in Xylem Inc. (NYSE:XYL)

Xylem logo with Business Services background

Keybank National Association OH lessened its stake in shares of Xylem Inc. (NYSE:XYL - Free Report) by 51.2% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 192,331 shares of the industrial products company's stock after selling 201,393 shares during the period. Keybank National Association OH owned 0.08% of Xylem worth $22,976,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. increased its stake in Xylem by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 28,644,417 shares of the industrial products company's stock valued at $3,323,325,000 after purchasing an additional 303,854 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Xylem by 2.4% in the 4th quarter. Geode Capital Management LLC now owns 5,804,247 shares of the industrial products company's stock valued at $671,623,000 after buying an additional 135,492 shares during the period. Royal Bank of Canada increased its position in Xylem by 7.9% in the 4th quarter. Royal Bank of Canada now owns 4,369,804 shares of the industrial products company's stock valued at $506,985,000 after buying an additional 320,500 shares in the last quarter. Invesco Ltd. raised its stake in Xylem by 9.8% during the 4th quarter. Invesco Ltd. now owns 4,009,907 shares of the industrial products company's stock worth $465,229,000 after buying an additional 359,276 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Xylem by 8.7% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,750,377 shares of the industrial products company's stock worth $435,119,000 after buying an additional 301,070 shares during the period. Institutional investors and hedge funds own 87.96% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the stock. Robert W. Baird reduced their price target on shares of Xylem from $149.00 to $146.00 and set an "outperform" rating for the company in a research report on Wednesday, April 30th. JPMorgan Chase & Co. began coverage on Xylem in a research note on Friday, May 30th. They issued an "overweight" rating and a $148.00 price objective on the stock. Stifel Nicolaus raised their price objective on shares of Xylem from $140.00 to $141.00 and gave the company a "buy" rating in a research report on Wednesday, April 30th. Raymond James Financial upgraded Xylem to a "hold" rating in a research report on Thursday, May 15th. Finally, Citigroup lowered their price objective on shares of Xylem from $152.00 to $134.00 and set a "buy" rating on the stock in a research report on Monday, April 14th. Three analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, Xylem has an average rating of "Moderate Buy" and an average target price of $143.71.

Read Our Latest Report on Xylem

Xylem Price Performance

NYSE XYL traded up $0.57 on Thursday, reaching $132.28. The company had a trading volume of 713,729 shares, compared to its average volume of 1,412,310. The stock has a market capitalization of $32.19 billion, a PE ratio of 35.56, a price-to-earnings-growth ratio of 2.38 and a beta of 1.12. The firm's 50 day moving average price is $125.21 and its 200 day moving average price is $121.91. The company has a quick ratio of 1.41, a current ratio of 1.89 and a debt-to-equity ratio of 0.18. Xylem Inc. has a 12 month low of $100.47 and a 12 month high of $143.50.

Xylem (NYSE:XYL - Get Free Report) last posted its quarterly earnings data on Tuesday, April 29th. The industrial products company reported $1.03 earnings per share for the quarter, beating analysts' consensus estimates of $0.95 by $0.08. Xylem had a net margin of 10.54% and a return on equity of 10.12%. The business had revenue of $2.07 billion for the quarter, compared to analysts' expectations of $2.04 billion. During the same quarter in the previous year, the business posted $0.90 earnings per share. The business's revenue was up 1.8% compared to the same quarter last year. As a group, equities analysts predict that Xylem Inc. will post 4.65 earnings per share for the current year.

Xylem Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, June 26th. Shareholders of record on Thursday, May 29th were paid a dividend of $0.40 per share. The ex-dividend date was Thursday, May 29th. This represents a $1.60 dividend on an annualized basis and a yield of 1.21%. Xylem's payout ratio is 43.01%.

Xylem Company Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

See Also

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines